Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
39
- +8 vs. Q1 2026
- Total value $3.35M
Superinvestors holding LGVN
0
- None of the superinvestors held LGVN at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by LGVN insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Aug 11, 2025 | Locklear LisaChief Financial Officer | PPurchaseClass A Common Stock | +11.77K | – | – | 250.96K | +4.9% | SEC |
| Aug 13, 2025 | Aug 11, 2025 | Locklear LisaChief Financial Officer | PPurchaseClass A Common Stock · Derivative | +29.42K | – | – | 29.42K | – | SEC |
| Aug 13, 2025 | Aug 11, 2025 | Baluch KhosoDirector | PPurchaseClass A Common Stock | +11.77K | – | – | 52.52K | +28.9% | SEC |
| Aug 13, 2025 | Aug 11, 2025 | Baluch KhosoDirector | PPurchaseClass A Common Stock · Derivative | +29.42K | – | – | 29.42K | – | SEC |
| Jun 2, 2025 | May 29 – May 30, 2025 | Soffer RockDirector | SSaleClass A Common Stock | −21K | $1.2738 | −$26.75K | 209.03K | −9.1% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in LGVN at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,353,881 | $951.78K | 0.00% | +907,156+203.1% | Added |
| Logos Global Management LP | 1,287,000 | $904.76K | 0.04% | +1,287,000 | New |
| VANGUARD CAPITAL MANAGEMENT LLC | 581,305 | $408.66K | 0.00% | +39,273+7.2% | Added |
| BlackRock, Inc. | 224,170 | $157.59K | 0.00% | −280.0% | Reduced |
| GEODE CAPITAL MANAGEMENT, LLC | 203,761 | $143.24K | 0.00% | +143+0.1% | Added |